Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication December 14, 2021
- Accepted for publication July 14, 2022
- Published online October 3, 2022.
Copyright & Usage
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.
Author Information
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
- Learning Objectives: On successful completion of this activity, participants should be able to (1) identify the dose (i.e., activity) prescription algorithms for radiopharmaceutical therapy and the advantages and disadvantages of each such algorithm; (2) describe the workflow for patient-specific dosimetry for radiopharmaceutical therapy; and (3) identify the advantages and disadvantages of α-particle emitters for radiopharmaceutical therapy.Financial Disclosure: Intellectual property of Dr. Zanzonico and collaborators has been licensed to Y-mAbs through an agreement between Memorial Sloan Kettering and Y-mAbs. The authors of this article have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest.CME Credit: SNMMI is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing education for physicians. SNMMI designates each JNM continuing education article for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only credit commensurate with the extent of their participation in the activity. For CE credit, SAM, and other credit types, participants can access this activity through the SNMMI website (http://www.snmmilearningcenter.org) through October 2025.
- For correspondence or reprints, contact Adam Kesner (kesnera{at}mskcc.org).